Exact Sciences Corp EXAS:NASDAQ

Last Price$116.34NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/17/19

Today's Change+1.39(1.21%)
Bid (Size)$96.50 (1)
Ask (Size)$117.47 (2)
Day Low / High$114.54 - 116.81
Volume843.0 K
 

View Biotechnology IndustryPeer Comparison as of 07/17/2019

 

Exact Sciences Corp ( NASDAQ )

Price: $116.34
Change: +1.39 (1.21%)
Volume: 843.0 K
4:00PM ET 7/17/2019
 
 

Biomarin Pharmaceutical Inc ( NASDAQ )

Price: $82.47
Change: +0.10 (0.12%)
Volume: 703.5 K
4:00PM ET 7/17/2019
 
 

Incyte Corp ( NASDAQ )

Price: $80.23
Change: +0.35 (0.44%)
Volume: 904.0 K
4:00PM ET 7/17/2019
 
 

Sarepta Therapeutics Inc ( NASDAQ )

Price: $154.00
Change: +0.75 (0.49%)
Volume: 686.1 K
4:00PM ET 7/17/2019
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 

Read more news Recent News

Exact Sciences, Mayo Clinic Collaboration Find Potential High-Sensitivity Biomarker for Pancreatic Cancer
10:12AM ET 5/20/2019 MT Newswires

A collaboration between Exact Sciences (EXAS) and the Mayo Clinic in identifying cancer biomarkers may have shown a way to potentially detect the most...

Exact Sciences Says New Data Reinforces Performance of Cologuard in Colorectal Cancer Screening
6:24AM ET 5/17/2019 MT Newswires

Exact Sciences (EXAS) said Friday that new research conducted by the company together with the Mayo Clinical demonstrated the ability of Cologuard to both...

MTNewswires After-Hours News Movers
5:52PM ET 4/30/2019 MT Newswires

Some of the stocks moving on news-driven events in Tuesday's after-hours include: STAF, +16.36% ARLO, +12.34% NUS, +10.58% TNDM, +7.64% AAPL, +4.65% VCYT,...

Exact Sciences Posts Wider-Than-Expected Q1 Loss; Revenue Tops
5:19PM ET 4/30/2019 MT Newswires

Exact Sciences (EXAS) shares fell more than 3% in extended trading on Tuesday after the molecular diagnostics company reported a wider-than-estimated Q1...

Company Profile

Business DescriptionEXACT Sciences Corp. is a molecular diagnostics company, which focuses on the early detection and prevention of colorectal cancer. It developed Cologuard, a screening test for the early detection of colorectal cancer and pre-cancer. The company was founded on February 10, 1995 and is headquartered in Madison, WI. View company web site for more details
Address441 Charmany Drive
Madison, Wisconsin 53719
Phone+1.608.284.5700
Number of Employees1,977
Recent SEC Filing06/27/201911-K
Chairman, President & Chief Executive OfficerKevin T. Conroy
Senior Vice President-OperationsAna Hooker
Chief Financial OfficerJeffrey T. Elliott
Co-Chief Medical Officer & Head-Medical AffairsBarry M. Berger

Company Highlights

Price Open$115.05
Previous Close$116.34
52 Week Range$47.78 - 121.98
Market Capitalization$15.0 B
Shares Outstanding129.1 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement07/30/2019

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$1.76
Beta vs. S&P 500N/A
Revenue$454.5 M
Net Profit Margin-41.58%
Return on Equity-29.98%

Analyst Ratings as of 07/05/2019

Buy
10
Overweight
1
Hold
1
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset